BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

690 related articles for article (PubMed ID: 21839126)

  • 1. Systemic delivery of siRNA with cationic lipid assisted PEG-PLA nanoparticles for cancer therapy.
    Yang XZ; Dou S; Sun TM; Mao CQ; Wang HX; Wang J
    J Control Release; 2011 Dec; 156(2):203-11. PubMed ID: 21839126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A biodegradable amphiphilic and cationic triblock copolymer for the delivery of siRNA targeting the acid ceramidase gene for cancer therapy.
    Mao CQ; Du JZ; Sun TM; Yao YD; Zhang PZ; Song EW; Wang J
    Biomaterials; 2011 Apr; 32(11):3124-33. PubMed ID: 21277018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous delivery of siRNA and paclitaxel via a "two-in-one" micelleplex promotes synergistic tumor suppression.
    Sun TM; Du JZ; Yao YD; Mao CQ; Dou S; Huang SY; Zhang PZ; Leong KW; Song EW; Wang J
    ACS Nano; 2011 Feb; 5(2):1483-94. PubMed ID: 21204585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo specific delivery of c-Met siRNA to glioblastoma using cationic solid lipid nanoparticles.
    Jin J; Bae KH; Yang H; Lee SJ; Kim H; Kim Y; Joo KM; Seo SW; Park TG; Nam DH
    Bioconjug Chem; 2011 Dec; 22(12):2568-72. PubMed ID: 22070554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-step assembly of cationic lipid-polymer hybrid nanoparticles for systemic delivery of siRNA.
    Yang XZ; Dou S; Wang YC; Long HY; Xiong MH; Mao CQ; Yao YD; Wang J
    ACS Nano; 2012 Jun; 6(6):4955-65. PubMed ID: 22646867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ScFv-decorated PEG-PLA-based nanoparticles for enhanced siRNA delivery to Her2⁺ breast cancer.
    Dou S; Yang XZ; Xiong MH; Sun CY; Yao YD; Zhu YH; Wang J
    Adv Healthc Mater; 2014 Nov; 3(11):1792-803. PubMed ID: 24947820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient inhibition of human colorectal carcinoma growth by RNA interference targeting polo-like kinase 1 in vitro and in vivo.
    Xu WJ; Zhang S; Yang Y; Zhang N; Wang W; Liu SY; Tian HW; Dai L; Xie Q; Zhao X; Wei YQ; Deng HX
    Cancer Biother Radiopharm; 2011 Aug; 26(4):427-36. PubMed ID: 21797676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triple negative breast cancer therapy with CDK1 siRNA delivered by cationic lipid assisted PEG-PLA nanoparticles.
    Liu Y; Zhu YH; Mao CQ; Dou S; Shen S; Tan ZB; Wang J
    J Control Release; 2014 Oct; 192():114-21. PubMed ID: 25016158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient delivery of Bcl-2-targeted siRNA using cationic polymer nanoparticles: downregulating mRNA expression level and sensitizing cancer cells to anticancer drug.
    Beh CW; Seow WY; Wang Y; Zhang Y; Ong ZY; Ee PL; Yang YY
    Biomacromolecules; 2009 Jan; 10(1):41-8. PubMed ID: 19072631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid-based nanoparticles for siRNA delivery in cancer therapy: paradigms and challenges.
    Gomes-da-Silva LC; Fonseca NA; Moura V; Pedroso de Lima MC; Simões S; Moreira JN
    Acc Chem Res; 2012 Jul; 45(7):1163-71. PubMed ID: 22568781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polo-like Kinase 1-targeting Chitosan Nanoparticles Suppress the Progression of Hepatocellular Carcinoma.
    Wang D; Chang R; Wang G; Hu B; Qiang Y; Chen Z
    Anticancer Agents Med Chem; 2017; 17(7):948-954. PubMed ID: 27671301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folate-linked lipid-based nanoparticles for synthetic siRNA delivery in KB tumor xenografts.
    Yoshizawa T; Hattori Y; Hakoshima M; Koga K; Maitani Y
    Eur J Pharm Biopharm; 2008 Nov; 70(3):718-25. PubMed ID: 18647651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix metalloproteinase 2-responsive micelle for siRNA delivery.
    Wang HX; Yang XZ; Sun CY; Mao CQ; Zhu YH; Wang J
    Biomaterials; 2014 Aug; 35(26):7622-34. PubMed ID: 24929619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlling HBV replication in vivo by intravenous administration of triggered PEGylated siRNA-nanoparticles.
    Carmona S; Jorgensen MR; Kolli S; Crowther C; Salazar FH; Marion PL; Fujino M; Natori Y; Thanou M; Arbuthnot P; Miller AD
    Mol Pharm; 2009; 6(3):706-17. PubMed ID: 19159285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polypeptide cationic micelles mediated co-delivery of docetaxel and siRNA for synergistic tumor therapy.
    Zheng C; Zheng M; Gong P; Deng J; Yi H; Zhang P; Zhang Y; Liu P; Ma Y; Cai L
    Biomaterials; 2013 Apr; 34(13):3431-8. PubMed ID: 23375952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of cationic nanoparticles of biodegradable copolymers as siRNA delivery system for hepatitis B treatment.
    Wang J; Feng SS; Wang S; Chen ZY
    Int J Pharm; 2010 Nov; 400(1-2):194-200. PubMed ID: 20801205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A biomimetic nanovector-mediated targeted cholesterol-conjugated siRNA delivery for tumor gene therapy.
    Ding Y; Wang W; Feng M; Wang Y; Zhou J; Ding X; Zhou X; Liu C; Wang R; Zhang Q
    Biomaterials; 2012 Dec; 33(34):8893-905. PubMed ID: 22979990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
    Li TS; Yawata T; Honke K
    Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study of growth inhibition of gastric cancer cells by sRNA targeting polo like kinase 1 in vitro and vivo].
    Lan B; Liu BY; Cheng XH; Qu Y; Zhang XQ; Cai Q; Dai QB; Zhu ZG
    Zhonghua Wai Ke Za Zhi; 2006 Jan; 44(1):40-4. PubMed ID: 16620646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gold nanoparticles capped with polyethyleneimine for enhanced siRNA delivery.
    Song WJ; Du JZ; Sun TM; Zhang PZ; Wang J
    Small; 2010 Jan; 6(2):239-46. PubMed ID: 19924738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.